Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

By Paola Rosanna   Cuzzocrea Salvatore  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 3, 2007-05 ,pp. : 157-175

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptors and the Control of Inflammation Update

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 297-298

Bentham Science Publishers

Access to resources Recommend Favorite

Development of a cell-based high-throughput peroxisome proliferator-activated receptors (PPARs) screening model and its application for evaluation of the extracts from Rhizoma Coptis

By Xia Zhi-Ning  

Journal of Asian Natural Products Research, Vol. 15, Iss. 3, 2013-03 ,pp. : 225-234

Taylor & Francis Ltd

Access to resources Recommend Favorite

Existing and potential therapeutic approaches targeting peroxisome proliferator-activated receptors in the management of Type 2 diabetes

By Stefanski Dr Adam   Majkowska Liliana  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. : 1713-1733

Informa Healthcare

Access to resources Recommend Favorite

PPAR Modulators and PPAR Pan Agonists for Metabolic Diseases: The Next Generation of Drugs Targeting Peroxisome Proliferator-Activated Receptors?

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 9, 2008-06 ,pp. : 728-749

Bentham Science Publishers

Access to resources Recommend Favorite